Search

Your search keyword '"HLA-DR Antigen"' showing total 1,139 results

Search Constraints

Start Over You searched for: Descriptor "HLA-DR Antigen" Remove constraint Descriptor: "HLA-DR Antigen"
1,139 results on '"HLA-DR Antigen"'

Search Results

1. HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine

2. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients

3. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: A meta-analysis of non-family-based studies

4. Novel autoantibody against the β2‐glycoprotein I/human leucocyte antigen– <scp>DR</scp> complex in patients with refractory cutaneous ulcers

5. Inhibitory effects of Triptolide on interferon-γ-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves’ ophthalmopathy.

6. Isolation and purification of HLA-DR antigen from Daudi cell line by immunoaffinity chromatography

7. The role of platelet microparticles in the production of antibodies from B lymphocytes against HLA-DR antigen in vitro

8. Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma

9. Predictive analysis for prognosis of CD14+ monocyte HLA-DR in geriatric trauma patients

10. Cyclodimerization of immunosuppressive fragment of HLA-DR molecule. Design, synthesis and ESI-MS/MS analysis

11. Possible association of human leucocyte antigen DR1 with delayed sleep phase syndrome.

12. BIOM-09. MULTIPLEX ANALYSIS OF CSF EXTRACELLULAR VESICLES OF INTRASPINAL TUMORS

13. Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition

14. HLA-DR and DQ antigens in Chinese patients with Behçet's disease.

15. Primary malignant lymphoma of the salivary gland: a tumor of mucosa-associated lymphoid tissue.

16. T lymphocytes, Langerhans cells and HLA-DR expression on keratinocytes in oral lesions associated with amalgam restorations.

17. Expression of HLA-DR antigen on hepatic vascular endothelial cells in idiopathic portal hypertension.

18. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.

19. Combined Expression of HLA-DR Antigen and Proliferating Cell Nuclear Antigen Correlate with Colorectal Cancer Prognosis.

20. Effect of UVB radiation on the biosynthesis of HLA-DR antigens.

21. Influence of LAK cells on expression of HLA-DR antigen on laryngeal carcinoma cell line in new culture systems.

22. Increased expression of HLA-DR antigen on alveolar macrophages in pulmonary diseases.

23. Epithelioid haemangioendothelioma of the bone tissue.

24. Molecular oncogene markers and their significance in cutaneous malignant melanoma.

25. Influence of pre-incubation with one antibody on the binding of a second by human lymphocytes.

26. Demonstration of the requirement for self antigen in the activation of autoreactive T cells.

27. FcγRIIIA-mediated activation of NK cells by IgG heavy chain complexed with MHC class II molecules

28. The role of monocytic myeloid-derived suppressor cells in the pathogenesis of endometriosis

29. Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 family

30. Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity

31. DC-HIL+ CD14+ HLA-DRno/low Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma

32. Differential regulation of MHCII genes by PRMT6, via an AT-hook motif of RFX5

33. A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells

34. Composition of the HLA-DR-associated human thymus peptidome

35. Co-regulated expression of alpha and beta mRNAs encoding HLA-DR surface heterodimers is mediated by the MHCII RNA operon

36. Clinical, Immunological and Genetic Findings of a Large Tunisian Series of Major Histocompatibility Complex Class II Deficiency Patients

38. TCR beta spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes

39. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition

40. Sampling from the proteome to the human leukocyte antigen-DR (HLA-DR) ligandome proceeds via high specificity

41. HLA typing by double ARMS

42. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores

43. Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals

44. HLA-DR products are a subset of human Ia antigens

45. Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples

46. Public T cell receptors confer high-avidity CD4 responses to HIV controllers

47. Design and validation of a novel generic platform for the production of tetravalent IgG1-like bispecific antibodies

48. Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition

49. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

50. Class II–Associated Invariant Chain Peptide Expression Represents a Novel Parameter for Flow Cytometric Detection of Acute Promyelocytic Leukemia

Catalog

Books, media, physical & digital resources